M. Armstrong

发表

Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events

James R. Staley, G. Pasterkamp, J. Staley, 2020, medRxiv.

Early-onset autoimmunity associated with SOCS1 haploinsufficiency

K. Schwarz, F. Rieux-Laucat, A. Fischer, 2020, Nature Communications.

SLITRK2 variants associated with neurodevelopmental disorders impair excitatory synaptic function and cognition in mice

J. Gécz, A. Bayat, J. Wynn, 2022, Nature Communications.

Towards realizing the vision of precision medicine: AI based prediction of clinical drug response

H. Fröhlich, I. Cutcutache, Cynthia Dilley, 2020, Brain : a journal of neurology.

Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature

D. Goldstein, S. Petrovski, B. Gorentla, 2016, Journal of Clinical Immunology.

A mouse model of human mitofusin-2-related lipodystrophy exhibits adipose-specific mitochondrial stress and reduced leptin secretion

Satish Patel, J. Prudent, S. Virtue, 2022, bioRxiv.

The Genetics of Adverse Drug Reactions

M. Armstrong, Martin Armstrong, 2008 .

Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans

James R. Staley, G. Pasterkamp, C. Vangjeli, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.

E. Bertini, V. Tiranti, R. Carrozzo, 2019, The Journal of clinical investigation.

Reverse Translation to Support Efficient Drug Target Selection and Stratified Medicine

M. Armstrong, L. Drowley, Martin Armstrong, 2019, Methods and Principles in Medicinal Chemistry.

Artificial intelligence-based clustering and characterization of Parkinson's disease trajectories

C. Birkenbihl, A. Avbersek, N. Massat, 2022, Scientific Reports.

Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression

T. Hansen, O. Pedersen, S. O’Rahilly, 2017, eLife.

Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.

Matthew H. Brush, David R. Murdock, Jean M. Davidson, 2019, Biological psychiatry.

Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)

J. Marshall, A. Chhibber, C. Paulding, 2021, Human Genetics.

Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants

J. Knight, K. Elliott, D. Pilz, 2021, Brain : a journal of neurology.